Literature DB >> 4869288

Hydroxyurea (NSC-32065) in therapy for nonresectable cancer of the lung.

D T Kaung, W S Walsh, S Sbar, M E Patno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4869288

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Phase 1 study of high-dose hydroxyurea in lung cancer.

Authors:  D Veale; B M Cantwell; N Kerr; A Upfold; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Cancer of the lung and its response to non-surgical treatment.

Authors:  A C Scheer; R F Wilson
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975

3.  The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

Authors:  P A Philip; L Kaklamanis; J Carmichael; K Tonkin; H Morrison; K Gatter; A L Harris
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.